Rise Nano Optics

Nanotechnology Eyewear Solutions

Health Tech & Life Sciences
Active
Pre-Funding Haifa, Israel Founded 2017
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2017
Headcount
2
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Rise develops nanotechnology eyewear solutions. Its filtering system blocks harmful sunlight wavelengths, reducing the risk of diabetes-related eye diseases, such as cataracts and retinopathy. Rise's technology can benefit the public at large, providing protection against harmful wavelengths in a wide variety of applications.

Rise's patented, second-generation solution uses advanced nanotechnology to effectively block harmful UV, blue light, and diabetes-spectrum wavelengths and reduce light intensity, using transparent lenses that do not require tinting. The nanotechnology solution successfully prevents the development and progress of diabetes-related cataracts and retinopathy.

Q&A

What is Rise Nano Optics' primary focus?
Rise Nano Optics develops nanotechnology eyewear solutions designed to filter harmful sunlight wavelengths and reduce the risk of diabetes-related eye diseases such as cataracts and retinopathy.
When was Rise Nano Optics founded?
Rise Nano Optics was founded in July 2017.
Where is Rise Nano Optics headquartered?
Rise Nano Optics is headquartered in Haifa, Israel.
What is the current employee count for Rise Nano Optics?
Rise Nano Optics has 1-10 employees.
Who is the Founder and CEO of Rise Nano Optics?
Inas Said is the Founder and CEO of Rise Nano Optics.
What is the current funding stage of Rise Nano Optics?
Rise Nano Optics is currently in the Pre-Funding stage.
Does Rise Nano Optics hold any patents?
Yes, Rise Nano Optics holds one patent for its technology.
What is the main benefit of Rise Nano Optics' patented technology?
Rise Nano Optics' patented, second-generation solution uses advanced nanotechnology to effectively block harmful UV, blue light, and diabetes-spectrum wavelengths, reducing light intensity with transparent lenses, and preventing the development and progress of diabetes-related cataracts and retinopathy.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Industrial ManufacturingDiscrete IndustriesSemiconductors & ElectronicsAutomotiveHealthcare & Life SciencesLife Sciences
Business model
B2B

Highlights

1 Patents

Tags

nanotechnologydiabetesdermatologynon-invasiveeye-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiterisenanooptics.com
LinkedInlinkedin.com/company/42296789

Identifiers & details

Founded2017-7
Employees (exact)2

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domainrisenanooptics.com

Certificate / subdomain footprint

Subdomains2